PDLIM7 and nasopharyngeal carcinoma: In this study, we designed a therapy remedy that combined the traditional chemotherapy drug MMC with a novel LMP1 antibody Fab, and evaluated the anti-cancer effects of this new combination therapy in NPC xenograft mice in vivo.